期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

恩替卡韦致严重肌痛1例 被引量：1

下载PDF
导出
摘要 患者，男性，37岁，因“食欲不振，轻度乏力”于2013年6月13日来我院就诊，既往患者无任何基础病变。查体：无明显阳性体征，查肝功能：ALT435U／L，AST387U／L；HBsAg（＋），
作者 陈建刚
机构地区 呼和浩特市第二人民医院感染科
出处 《肝脏》 2014年第4期303-304,共2页 Chinese Hepatology
关键词 恩替卡韦 HBSAG(+) 肌痛 食欲不振 轻度乏力 基础病变 阳性体征 肝功能
分类号 R595.3 [医药卫生—内科学]
  • 相关文献

参考文献1

二级参考文献31

  • 1[1]Lee WM.Hepatitis B virus infection.N Engl J Med 1997; 337:1733-1745
  • 2[2]Mohanty SR,Kupfer SS,Khiani V.Treatment of chronic hepatitis B.Nat Clin Pract Gastroenterol Hepatol 2006; 3:446-458
  • 3[3]Beasley RP.Hepatitis B virus.The major etiology of hepatocellular carcinoma.Cancer 1988; 61:1942-1956
  • 4[4]McMahon BJ,Holck P,Bulkow L,Snowball M.Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.Ann Intern Med 2001; 135:759-768
  • 5[5]Parkin DM,Bray F,Ferlay J,Pisani P.Estimating the world cancer burden:Globocan 2000.Int J Cancer 2001; 94:153-156
  • 6[6]Fung SK,Lok AS.Drug insight:Nucleoside and nucleotide analog inhibitors for hepatitis B.Nat Clin Pract Gastroenterol Hepatol 2004; 1:90-97
  • 7[7]Chowdhury A.Epidemiology of hepatitis B virus infection in India.Hep B Annual 2004; 1:17-24
  • 8[8]Thyagrajan SP,Jayaram S,Hari R,Mohan KVK,Murugavel KG.Epidemiology of hepatitis B in India-A comprehensive analysis.In:Hepatitis B and C carrier to cancer.Sarin SK,Okuda K,editors.1st ed.New Delhi:Harcourt India Private Ltd,2002:25-39
  • 9[9]Tandon BN,Acharya SK,Tandon A.Epidemiology of hepatitis B virus infection in India.Gut 1996; 38 Suppl 2:S56-S59
  • 10[10]Chowdhury A,Santra A,Pal S,Chakravarty R,Banerji A,Pal S,Dhali GK,Datta S,Banerji.S,Manna B,Roy Chowdhury S,Bhattacharya SK,Guha Mazumder D.Community based epidemiological study of Hepatitis B virus infection (HBV).Indian Journal Gastroenterol 2001; 20 Suppl 2:A2

共引文献26

同被引文献24

  • 1Mustafa Kemal C,Tuba D, Celal A, et al. Four-year study of entecavir efficacy and safety in nucleos (t)ide-naive HBeAg positive chronic hepatitis B patients[J]. Acta Clinica Croatica,2014,53(1) :31-36.
  • 2Yang SC, Lee CM, Hu TH, et al. Virological response to entecavir re- duces the risk of liver disease progression in nucleos (t) ide analogue- experienced HBV-infected patients with prior resistant mutants [ J ]. Journal of Antimicrobial Chemotherapy ,2013,68 ( 9 ) :2154-2163.
  • 3Ahn J, Lee HM, Lim JK, et al. Entecavir safety and effectiveness in a national cohort of treatment-naYve chronic hepatitis B patients in the US-the ENUMERATE study [ J 1. Alimentary Pharmacology & Thera- peutics,2015,43 ( 1 ) : 134-144.
  • 4Tsai MC, Chen CH, Hung CH, et al. A comparison of efficacy and safe- ty of 2-year telbivudine and entecavir treatment in patients with chron- ic hepatitis B:a match-control study [ J ]. Clinical Microbiology and In- fection ,2014,20 ( 2 ) :90-100.
  • 5Wiens A, Lenzi L, Venson R, et al. Comparative Efficacy of Oral Nu- cleoside or Nucleotide Analog Monotherapy Used in Chronic HepatitisB : A Mixed-Treatment Comparison Meta-analysis [ J ]. Phannacothera- py : The Journal of Human Pharmacology and Drug Therapy, 2013,33 (2) :144-151.
  • 6Toy M, Hutton DW, So SK, et al. Cost-Effectiveness and Cost Thresh- olds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China[ J]. Plos One,2015,10( 11 ) :526-535.
  • 7Wiens A, Lenzi L, Venson R, et al. Economic evaluation of treatments for chronic hepatitis B [ J]. The Brazilian Journal of Infectious Disea- ses,2013,17(4) :418-426.
  • 8Wang G, Liu Y, Qiu P, et al. Cost-effectiveness analysis of lamivudi- ne, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance [ J ]. Drug design, development and thera- py,2015,12(9) :2839-2846.
  • 9Preda CM, Baicus C, Negreanu L, et al. Effectiveness of entecavir treatment and predictive factors for virologic response [ J ]. Revista Espanola De Enfermedades Digestivas Organo Oficial De La Sociedad Espanola De Patologia Digestiva, 2014,106 ( 5 ) :305-311.
  • 10Gines PP, Lenz K, Moiler S, et al. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis [ J]. Journal of Hepatology,2010, 53(3) :397-417.

引证文献1

二级引证文献17

肝脏
2014年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部